IO Biotech Hosting Key Opinion Leader Webinar Series
Part 1: A New Way to Kill Tumors–IO102-IO103 Phase 3 Trial in Combination with Anti-PD-1 in Advanced Melanoma Thursday, April...
News
Stella Diagnostics Announces Leadership Changes: Dr. Joe Abdo Assumes a New Role as Chief Scientific Officer, and Director David Seaburg is Appointed Chief Executive Officer
SALT LAKE CITY, April 22, 2022 (GLOBE NEWSWIRE) -- Stella Diagnostics, Inc. (OTC: SLDX), a molecular diagnostics-based organization optimizing patient...
Salarius Pharmaceuticals, Inc. Announces $2.3 Million Registered Direct Offering
HOUSTON, April 22, 2022 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical company developing cancer therapies for...
Medexus Pharmaceuticals Announces Resubmission of Treosulfan NDA
Additional data collection and analysis reconfirms confidence in New Drug Application for TreosulfanNDA resubmission date consistent with previously announced timelineFDA...
SCYNEXIS Announces Pricing of $45 Million Public Offering of Common Stock, Pre-Funded Warrants and Warrants
JERSEY CITY, N.J., April 22, 2022 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (Nasdaq: SCYX) today announced the pricing of its underwritten...
Opthea strengthens its Board of Directors
Elects Mr. Quinton Oswald and Dr. Susan Orr, deeply experienced Ophthalmology Executives, at a General Meeting of ShareholdersMELBOURNE, Australia, April 22, 2022 (GLOBE NEWSWIRE) --...
BioLexis Reorganization Results in GMS Holdings as Largest Shareholder in Outlook Therapeutics
SINGAPORE and ISELIN, N.J., April 22, 2022 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a pre-commercial biopharmaceutical company working to...
Entourage Updates Timing of Fiscal Year 2021 Financial Results Call to May 3, 2022
Company reaffirms preliminary fiscal year 2021 record revenue of $54.8 million(1)Results to be filed after-market May 2, 2022, with management...
Vallon Pharmaceuticals Announces Review of Strategic Alternatives
Philadelphia, PA, April 22, 2022 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or the “Company”), a clinical-stage biopharmaceutical...
Ultragenyx Appoints Amrit Ray, M.D., M.B.A. to Board of Directors
Physician researcher and biopharmaceutical executive to join R&D Committee Amrit Ray, M.D., M.B.A. Amrit Ray, M.D., M.B.A.NOVATO, Calif., April 22,...
SCYNEXIS Announces Positive Interim Data from Phase 3 FURI and CARES Studies Highlighting Oral Ibrexafungerp’s Potency Against Severe Fungal Infections
Data reinforce findings from previous analyses demonstrating oral ibrexafungerp’s potential to combat difficult-to-treat and refractory fungal infections in the hospital...
Jasper Therapeutics to Host In-Person Key Opinion Leader Webinar on Transforming Hematopoietic Stem Cell Therapies
REDWOOD CITY, Calif., April 22, 2022 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ: JSPR), a biotechnology company focused on hematopoietic...
Fate Therapeutics to Webcast Conference Call Reporting First Quarter 2022 Financial Results
SAN DIEGO, April 22, 2022 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage biopharmaceutical...
Simply Better Brands Corp. Announces Shares for Debt Transaction
VANCOUVER, British Columbia, April 22, 2022 (GLOBE NEWSWIRE) -- Simply Better Brands Corp. ("SBBC" or the "Company") (TSX Venture: SBBC,...
CloudMD Announces Resignation of Director
VANCOUVER, British Columbia, April 22, 2022 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH)...
Emerging Markets Report: More Tools in the Toolbox
An Emerging Markets Sponsored Commentary ORLANDO, Fla., April 22, 2022 (GLOBE NEWSWIRE) -- Sometimes as we continue our coverage of...
CareDx Demonstrates Potential of AlloHeme and AlloCell for Allogeneic Cell Transplant and Therapy Monitoring at Transplantation & Cellular Therapy Meetings
CareDx Announces that OTTR Patient Management Software Now Validated for SMART on FHIRSOUTH SAN FRANCISCO, Calif., April 22, 2022 (GLOBE...
PLx Pharma Inc. to Discuss 2022 First Quarter Financial Results on May 13, 2022 Conference Call and Provide Business Update
SPARTA, N.J., April 22, 2022 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”) is a commercial-stage drug...
InvestmentPitch Media Video Discusses Reliq Health’s Signing of New Contracts in California, Texas and Nevada, with Two Physician Practices, a Hospital and a Skilled Nursing Facility
VANCOUVER, British Columbia, April 22, 2022 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT) (OTCPink:RQHTF) (FSE:MHN2), a rapidly growing global...
Orion’s collaboration partner Bayer submits application for additional indication of darolutamide in China
ORION CORPORATION PRESS RELEASE 22 April 2022 at 11.30 EEST Orion’s collaboration partner Bayer submits application for additional indication of darolutamide...
